52 matches.
- Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake
- FDA Releases Laboratory-Developed Tests Final Rule
- Spilling Secrets: Navigating Physician Non-Compete Litigation
- Key Changes in Finalized Antitrust Merger Guidelines
- Braidwood v. Becerra: Challenging the Affordable Care Act’s Preventive Services Coverage Provision
- Spilling Secrets: Latest Developments – Restrictive Covenants in the Health Care Industry
- Health Equity: Behind the Buzzwords
- Telehealth Post-Public Health Emergency: What to Expect in 2024
- Dietary Supplements: Navigating the Regulatory Maze
- Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
- Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
- Owner’s Outlook: Managing Risks in an Ever-Changing Construction Environment
- Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
- Post-Dobbs: One Year Later
- Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
- Spilling Secrets: How to Secure Key Employees in Health Care M&A Transactions
- The Legal Battle Over Mifepristone
- Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
- Direct Access Laboratory Testing: Physician Orders and Specimen Collection
- Legal and Regulatory Landscape for Psychedelics as Therapies
- 2023 Deal Cycle: Considerations for Transactions in Uncertain Economic Times
- The End of the Public Health Emergency – What’s to Come?
- Direct Access Laboratory Testing: Reimbursement & Compliance
- Direct Access Laboratory Testing: Navigating the Regulatory Landscape
- Unpacking FDA's Final Clinical Decision Support Guidance
- Post-Dobbs: Considerations for Clinical Trials and Research
- Career Pathways: Epstein Becker Green Expanding in Nashville
- Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
- Owner's Outlook: National Trends in Construction Claims
- Post-Dobbs: Navigating the Fast-Changing and Uncertain Legal Landscape
- Health Care's Past, Present, and Future
- Hot Areas in COVID-19 Enforcement, Testing, and Funding
- Owner’s Outlook: HCA’s Clint Russell on Health Care Construction Pricing and Innovation
- Owner’s Outlook: Maximize and Safeguard Reimbursement Through Design
- Interoperability: Information Blocking Claims and Enforcement
- Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
- Owner’s Outlook: Renovating and Expanding Critical Access Hospitals in a Volatile Market
- Interoperability: Health Care's Next Disruptor Is openEHR
- Interoperability: A New Vision Through openEHR
- Owner's Outlook: Health Care Construction in a Period of Labor Shortages / Cost Inflation
- The Opportunities and Challenges Ahead for Biopharma and Public Health – Richard Hughes
- Entrepreneurship in Biotech: Growing Your Business
- Interoperability: The Role of Health Information Exchanges
- Interoperability: The Provider Perspective
- Owner’s Outlook: Vaccine Mandate for Construction Workers at Health Care Facilities
- Chevron Deference: Is It Time for Change?
- Interoperability: How Far We’ve Come and Where We’re Going
- No Surprises Act: New Rules and Guidance for Stakeholders (Part 2)
- No Surprises Act: New Rules and Guidance for Stakeholders (Part 1)
- Getting Ready for the No Surprises Act
- How Will Biden’s Executive Order Impact Future Hospital Mergers?
- What Is the Future of the Acute Care Hospital Industry?